Talking Euretina
A podcast by Whipsmart Media
Categories:
50 Episodes
-
Episode 29: How to get published in Euretina’s Journal, Ophthalmologica
Published: 4/14/2023 -
Episode 28: Diabetic Retinopathy - the latest exciting developments from across the world
Published: 3/30/2023 -
Episode 27: What do we mean by ”macula-off” RRD ... and how soon should we act?
Published: 3/14/2023 -
Episode 26: Tackling Acute Retinal Necrosis in Patients
Published: 3/1/2023 -
Episode 25: What individual patient data can tell us about treating macular holes
Published: 2/15/2023 -
Episode 24: Five Years after Approval of Voretigene Neparvovec – What is The Future of Retinal Gene Therapy?
Published: 2/6/2023 -
Episode 23: Everything You Need to Know About the New EBO-Euretina Exam
Published: 1/17/2023 -
Episode 22: Women in Retina
Published: 12/1/2022 -
Episode 21: What To Know About The Bad Guy In Myopia: Staphyloma
Published: 11/17/2022 -
Episode 20: A Deep Dive into the MOLES System
Published: 11/3/2022 -
Episode 19: Exploring the Data from the Derby and Oaks Trials
Published: 10/20/2022 -
Episode 18: Highlights Continued: The EURETINA Sessions
Published: 9/24/2022 -
Episode 17: Highlights from Euretina Congress in Hamburg
Published: 9/8/2022 -
Episode 16: Euretina Speaker Spotlight: Prof Hiroko Terasaki and Dr Enrico Borrelli
Published: 8/16/2022 -
Episode 15: Euretina Congress Keynotes
Published: 8/3/2022 -
Talking Euretina Summer Break
Published: 7/25/2022 -
Episode 14: Non-invasive Imaging in Diabetic Retinopathy and Other Retinal Diseases
Published: 6/30/2022 -
Episode 13: Choroidal Naevi in Daily Practice: Imaging, Follow-ups and the MOLES System
Published: 6/16/2022 -
Episode 12: Journal Club - Subretinal Hemorrhages and the TIGER study
Published: 6/1/2022 -
Episode 11: Imaging and AMD - Pathology, Biomarkers and Big Data
Published: 5/16/2022
Expert Discussions from the World of Retina: Exploring the latest developments in the field with world-renowned leaders. It will feature a monthly subspecialty journal club, panel discussions and interviews with key opinion leaders.